Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jun;19(3):183-7.
doi: 10.1016/j.siny.2013.11.013. Epub 2013 Dec 14.

A historical and practical review of first trimester aneuploidy screening

Melissa L Russo  1 , Karin J Blakemore  2
Affiliations
Review

A historical and practical review of first trimester aneuploidy screening

Melissa L Russo et al. Semin Fetal Neonatal Med. 2014 Jun.

Abstract

There have been tremendous advancements over the past three decades in prenatal screening for aneuploidy and we have changed our practice from screening by maternal age alone to 'combined' first trimester screening and circulating cell-free fetal DNA. We currently use the nuchal translucency and biochemical markers of free β-hCG and PAPP-A to determine the risk of fetal aneuploidy. The primary goal is to identify higher risk women for fetal aneuploidy early in pregnancy and give them the option to pursue invasive testing in a timely manner if desired.

Keywords: Aneuploidy; First trimester screening; Free β-human chorionic gonadotropin; Maternal serum screening tests; Nuchal translucency measurement; Pregnancy-associated plasma protein A.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement

None declared.

References

    1. Penrose LS. The Colchester Survey: a clinical and genetic study of 1280 cases of mental defect London: HMSO/Privy Council of Medical Research Council; 1938.
    1. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum alpha–fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984;148:886–94. - PubMed
    1. Cuckle HS, Wald NJ, Lindenbaum RH. Maternal serum alpha–fetoprotein measurement: a screening test for Down syndrome. Lancet 1984;323:926–9. - PubMed
    1. Macri JN, Kasturi RV, Krantz DA, Cook EJ, Moore ND, Young JA, et al. Maternal serum Down syndrome screening: free beta–protein is a more effective marker than human chorionic gonadotropin. Am J Obstet Gynecol 1990;163(4 Pt 1):1248–53. - PubMed
    1. Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down’s syndrome. BrJ Obstet Gynaecol 1988;95:330–3. - PubMed